Acyl-CoA: cholesterol acyltransferase (ACAT), plays an essential role both in intestinal absorption of cholesterol and cholesteryl ester formation in a variety of tissues and cells1}. Since elevated plasma level of cholesterol is related to an increased risk of coronary heart disease2} and massive accumulation of cholesteryl esters in macrophage-derived foam cells is a hallmark of the atherosclerotic plaques3), controlling ACATactivity may be of importance in prevention and treatment of atherosclerosis.
In the search for microbial metabolites which inhibit cholesteryl ester formation in macrophages, we isolated a new inhibitor of ACAT,named gypsetin ( Fig. 1) . In this paper, we describe the fermentation, isolation, physico-chemical properties and biological activity of gypsetin. Details of the structure elucidation of gypsetin will be reported in the accompanyingpaper4). The configuration shown is relative one. FEB. 1994 Fermentati on N. gypsea var. incurvata IFO 9228 (original deposition; accession number IMI 86518 of the CAB International Mycological Institute, Ferrylane, Kew, England) obtained from the Institute for Fermentation, Osaka, Japan, was aerobically grown at 25°C in a medium containing 3% glucose, 1% soybean meal, 0.3% meat extract, 0.3% Polypepton, 0.3% yeast extract, 0.05% KH2PO4, 0.05% MgSO4-7H2O and 0.01% CB442 (pH 5.9). The above-mentioned medium (100ml in a 500-ml Sakaguchi flask) was inoculated with the mycelial scrapings from the slant culture and incubated on a reciprocal shaker (1 20 rpm) at 25°C for two days. One milliliter portion of this seed culture was inoculated into the same medium (100ml in a 500-ml Sakaguchi flask). The flask was incubated under the same conditions as above for 7days. A typical time course of the fermentation is shown in Fig. 2 .
Isolation
The cultured broth (3 liters) was filtered to separate the filtrate and mycelial cake. The latter was extracted three times with 1 liter each of acetone. The acetone extract was evaporated to removethe organic solvent and combined with the culture filtrate. After adjusting at pH 8 with NaOH,the combined mixture was extracted with dichloromethane (twice with 3 liters each followed by once with 1 liter). The solvent layer was dried over anhydrous sodium sulfate and concentrated to dryness, giving 1.47 g of a residue.
This material was applied to a silica gel column 296 (4,430) IR vmax (KBr) cm "1 3500, 3360, 2960, 2930, 2870, 2350, 1670, 1600, 1480, 1460, 1360, 1080 Nannizzia gypsea var. incurvata IFO 9228 was grown aerobically as described in the text. One milliliter aliquot of the cultured broth was removed everyday and extracted three times with 1 ml each of dichloromethane after adjusting at pH 8. Portions of concentrated extracts were analyzed by HPLC(column; Inertsil PREP-ODS(6 x 250 mm), mobile phase; 80% aq acetonitrile, detection; absorbance at 220 nm) and quantified using purified gypsetin as a standard. represents the average of duplicate determinations. The meancontrol values were 1.57 and 14.5 nmol/3 hours/ mg cell protein for the incorporation into cholesteryl ester and triacylglycerol, respectively. FEB. 1994 gypsetin was determined to be C32H36N4O4 by a combination of HREI-MS, SI-MS and 13C NMR analyses. The UVabsorption spectrum was essentially unaltered when it was measured either in MeOH-0.1M NaOH (60: 1) or in MeOH-0.1m HC1 (60: 1). The IR absorption bands at 3600-3300 and 1670 cm" 1 are consistent with the presence of hydroxyl and carbonyl groups, respectively.
Biological Activity ACATInhibition
ACAT activity was determined as described previously5* with slight modifications.
Details are shown in the legend to Fig. 3 . Gypsetin inhibited microsomal ACATactivity 50% at a concentration of 18 /im (Fig. 3) . Whenthe microsomes treated with 61^m gypsetin were washed with buffer as described previously5), they recovered from inhibition of ACATactivity (Table 2 ). Inhibition kinetics were determined by measuring the enzyme activity at the various concentrations of both [14C]oleoyl-CoA and gypsetin. Double reciprocal plots of the data suggested that the inhibition is competitive with respect to the substrate [14C]oleoyl-CoA (Fig. 4) . The apparent Ki value was calculated to be 5.5 /zm.
Inhibition of Cholesteryl Ester Formation in Macrophages
When incubated with oxidized low density lipoprotein (LDL), macrophages avidly take up and degrade the lipoprotein, resulting in the formation of cholesteryl esters. This activity, as measured by incorporation of [14C]oleate into cholesteryl ester6), was inhibited 50%by gypsetin at a concentration of 0.65 fM, while [14C]oleate incorporation into triacylglycerol was increased by 1.5-fold (Fig. 5) . Under the similar conditions where 125I-labeled oxidized LDLwas used in place of oxidized LDL, gypsetin did not inhibit cell surface binding, uptake and degradation of oxidized 125I-LDL (data not shown).
Discussion
A new microbial metabolite, gypsetin, was isolated from the cultured broth of N. gypsea var. incurvata IFO 9228 as a competitive inhibitor of ACAT.Gypsetin inhibition of cholesteryl ester formation in the cultured macrophages (IC5O =0.65 /im) was 27-fold more potent than that in the cell-free ACATassay under the conditions used in this study. Since, gypsetin inhibited neither surface binding, uptake nor degradation of oxidized 125I-LDL, its inhibition of cholesteryl ester formation in macrophages may, at least partly, be ascribed to the inhibition of ACAT.The apparent discrepancy in the inhibitory potency of gypsetin between in the macrophageand the cell-free assays mayarise from a difference in the conditions where ACATexcerts its activity; for example, availability of the substrate, cholesterol and oleoyl-CoA, may affect the potency of the agent. Weand others have observed similar results that several other ACAT inhibitors are 5-to 100-fold more potent in macrophage assays than in cell-free ones7~9).
